PNG  IHDRQgAMA a cHRMz&u0`:pQ<bKGDgmIDATxwUﹻ& ^CX(J I@ "% (** BX +*i"]j(IH{~R)[~>h{}gy)I$Ij .I$I$ʊy@}x.: $I$Ii}VZPC)I$IF ^0ʐJ$I$Q^}{"r=OzI$gRZeC.IOvH eKX $IMpxsk.쒷/&r[޳<v| .I~)@$updYRa$I |M.e JaֶpSYR6j>h%IRز if&uJ)M$I vLi=H;7UJ,],X$I1AҒJ$ XY XzI@GNҥRT)E@;]K*Mw;#5_wOn~\ DC&$(A5 RRFkvIR}l!RytRl;~^ǷJj اy뷦BZJr&ӥ8Pjw~vnv X^(I;4R=P[3]J,]ȏ~:3?[ a&e)`e*P[4]T=Cq6R[ ~ޤrXR Հg(t_HZ-Hg M$ãmL5R uk*`%C-E6/%[t X.{8P9Z.vkXŐKjgKZHg(aK9ڦmKjѺm_ \#$5,)-  61eJ,5m| r'= &ڡd%-]J on Xm|{ RҞe $eڧY XYrԮ-a7RK6h>n$5AVڴi*ֆK)mѦtmr1p| q:흺,)Oi*ֺK)ܬ֦K-5r3>0ԔHjJئEZj,%re~/z%jVMڸmrt)3]J,T K֦OvԒgii*bKiNO~%PW0=dii2tJ9Jݕ{7"I P9JKTbu,%r"6RKU}Ij2HKZXJ,妝 XYrP ެ24c%i^IK|.H,%rb:XRl1X4Pe/`x&P8Pj28Mzsx2r\zRPz4J}yP[g=L) .Q[6RjWgp FIH*-`IMRaK9TXcq*I y[jE>cw%gLRԕiFCj-ďa`#e~I j,%r,)?[gp FI˨mnWX#>mʔ XA DZf9,nKҲzIZXJ,L#kiPz4JZF,I,`61%2s $,VOϚ2/UFJfy7K> X+6 STXIeJILzMfKm LRaK9%|4p9LwJI!`NsiazĔ)%- XMq>pk$-$Q2x#N ؎-QR}ᶦHZډ)J,l#i@yn3LN`;nڔ XuX5pF)m|^0(>BHF9(cզEerJI rg7 4I@z0\JIi䵙RR0s;$s6eJ,`n 䂦0a)S)A 1eJ,堌#635RIgpNHuTH_SԕqVe ` &S)>p;S$魁eKIuX`I4춒o}`m$1":PI<[v9^\pTJjriRŭ P{#{R2,`)e-`mgj~1ϣLKam7&U\j/3mJ,`F;M'䱀 .KR#)yhTq;pcK9(q!w?uRR,n.yw*UXj#\]ɱ(qv2=RqfB#iJmmL<]Y͙#$5 uTU7ӦXR+q,`I}qL'`6Kͷ6r,]0S$- [RKR3oiRE|nӦXR.(i:LDLTJjY%o:)6rxzҒqTJjh㞦I.$YR.ʼnGZ\ֿf:%55 I˼!6dKxm4E"mG_ s? .e*?LRfK9%q#uh$)i3ULRfK9yxm܌bj84$i1U^@Wbm4uJ,ҪA>_Ij?1v32[gLRD96oTaR׿N7%L2 NT,`)7&ƝL*꽙yp_$M2#AS,`)7$rkTA29_Iye"|/0t)$n XT2`YJ;6Jx".e<`$) PI$5V4]29SRI>~=@j]lp2`K9Jaai^" Ԋ29ORI%:XV5]JmN9]H;1UC39NI%Xe78t)a;Oi Ҙ>Xt"~G>_mn:%|~ޅ_+]$o)@ǀ{hgN;IK6G&rp)T2i୦KJuv*T=TOSV>(~D>dm,I*Ɛ:R#ۙNI%D>G.n$o;+#RR!.eU˽TRI28t)1LWϚ>IJa3oFbu&:tJ*(F7y0ZR ^p'Ii L24x| XRI%ۄ>S1]Jy[zL$adB7.eh4%%누>WETf+3IR:I3Xה)3אOۦSRO'ٺ)S}"qOr[B7ϙ.edG)^ETR"RtRݜh0}LFVӦDB^k_JDj\=LS(Iv─aTeZ%eUAM-0;~˃@i|l @S4y72>sX-vA}ϛBI!ݎߨWl*)3{'Y|iSlEڻ(5KtSI$Uv02,~ԩ~x;P4ցCrO%tyn425:KMlD ^4JRxSهF_}شJTS6uj+ﷸk$eZO%G*^V2u3EMj3k%)okI]dT)URKDS 7~m@TJR~荪fT"֛L \sM -0T KfJz+nإKr L&j()[E&I ߴ>e FW_kJR|!O:5/2跌3T-'|zX ryp0JS ~^F>-2< `*%ZFP)bSn"L :)+pʷf(pO3TMW$~>@~ū:TAIsV1}S2<%ޟM?@iT ,Eūoz%i~g|`wS(]oȤ8)$ ntu`өe`6yPl IzMI{ʣzʨ )IZ2= ld:5+請M$-ї;U>_gsY$ÁN5WzWfIZ)-yuXIfp~S*IZdt;t>KūKR|$#LcԀ+2\;kJ`]YǔM1B)UbG"IRߊ<xܾӔJ0Z='Y嵤 Leveg)$znV-º^3Ւof#0Tfk^Zs[*I꯳3{)ˬW4Ւ4 OdpbZRS|*I 55#"&-IvT&/윚Ye:i$ 9{LkuRe[I~_\ؠ%>GL$iY8 9ܕ"S`kS.IlC;Ҏ4x&>u_0JLr<J2(^$5L s=MgV ~,Iju> 7r2)^=G$1:3G< `J3~&IR% 6Tx/rIj3O< ʔ&#f_yXJiގNSz; Tx(i8%#4 ~AS+IjerIUrIj362v885+IjAhK__5X%nV%Iͳ-y|7XV2v4fzo_68"S/I-qbf; LkF)KSM$ Ms>K WNV}^`-큧32ŒVؙGdu,^^m%6~Nn&͓3ŒVZMsRpfEW%IwdǀLm[7W&bIRL@Q|)* i ImsIMmKmyV`i$G+R 0tV'!V)֏28vU7͒vHꦼtxꗞT ;S}7Mf+fIRHNZUkUx5SAJㄌ9MqμAIRi|j5)o*^'<$TwI1hEU^c_j?Е$%d`z cyf,XO IJnTgA UXRD }{H}^S,P5V2\Xx`pZ|Yk:$e ~ @nWL.j+ϝYb퇪bZ BVu)u/IJ_ 1[p.p60bC >|X91P:N\!5qUB}5a5ja `ubcVxYt1N0Zzl4]7­gKj]?4ϻ *[bg$)+À*x쳀ogO$~,5 زUS9 lq3+5mgw@np1sso Ӻ=|N6 /g(Wv7U;zωM=wk,0uTg_`_P`uz?2yI!b`kĸSo+Qx%!\οe|އԁKS-s6pu_(ֿ$i++T8=eY; צP+phxWQv*|p1. ά. XRkIQYP,drZ | B%wP|S5`~́@i޾ E;Չaw{o'Q?%iL{u D?N1BD!owPHReFZ* k_-~{E9b-~P`fE{AܶBJAFO wx6Rox5 K5=WwehS8 (JClJ~ p+Fi;ŗo+:bD#g(C"wA^ r.F8L;dzdIHUX݆ϞXg )IFqem%I4dj&ppT{'{HOx( Rk6^C٫O.)3:s(۳(Z?~ٻ89zmT"PLtw䥈5&b<8GZ-Y&K?e8,`I6e(֍xb83 `rzXj)F=l($Ij 2*(F?h(/9ik:I`m#p3MgLaKjc/U#n5S# m(^)=y=đx8ŬI[U]~SцA4p$-F i(R,7Cx;X=cI>{Km\ o(Tv2vx2qiiDJN,Ҏ!1f 5quBj1!8 rDFd(!WQl,gSkL1Bxg''՞^ǘ;pQ P(c_ IRujg(Wz bs#P­rz> k c&nB=q+ؔXn#r5)co*Ũ+G?7< |PQӣ'G`uOd>%Mctz# Ԫڞ&7CaQ~N'-P.W`Oedp03C!IZcIAMPUۀ5J<\u~+{9(FbbyAeBhOSܳ1 bÈT#ŠyDžs,`5}DC-`̞%r&ڙa87QWWp6e7 Rϫ/oY ꇅ Nܶըtc!LA T7V4Jsū I-0Pxz7QNF_iZgúWkG83 0eWr9 X]㾮݁#Jˢ C}0=3ݱtBi]_ &{{[/o[~ \q鯜00٩|cD3=4B_b RYb$óBRsf&lLX#M*C_L܄:gx)WΘsGSbuL rF$9';\4Ɍq'n[%p.Q`u hNb`eCQyQ|l_C>Lb꟟3hSb #xNxSs^ 88|Mz)}:](vbۢamŖ࿥ 0)Q7@0=?^k(*J}3ibkFn HjB׻NO z x}7p 0tfDX.lwgȔhԾŲ }6g E |LkLZteu+=q\Iv0쮑)QٵpH8/2?Σo>Jvppho~f>%bMM}\//":PTc(v9v!gոQ )UfVG+! 35{=x\2+ki,y$~A1iC6#)vC5^>+gǵ@1Hy٪7u;p psϰu/S <aʸGu'tD1ԝI<pg|6j'p:tպhX{o(7v],*}6a_ wXRk,O]Lܳ~Vo45rp"N5k;m{rZbΦ${#)`(Ŵg,;j%6j.pyYT?}-kBDc3qA`NWQū20/^AZW%NQ MI.X#P#,^Ebc&?XR tAV|Y.1!؅⨉ccww>ivl(JT~ u`ٵDm q)+Ri x/x8cyFO!/*!/&,7<.N,YDŽ&ܑQF1Bz)FPʛ?5d 6`kQձ λc؎%582Y&nD_$Je4>a?! ͨ|ȎWZSsv8 j(I&yj Jb5m?HWp=g}G3#|I,5v珿] H~R3@B[☉9Ox~oMy=J;xUVoj bUsl_35t-(ՃɼRB7U!qc+x4H_Qo֮$[GO<4`&č\GOc[.[*Af%mG/ ňM/r W/Nw~B1U3J?P&Y )`ѓZ1p]^l“W#)lWZilUQu`-m|xĐ,_ƪ|9i:_{*(3Gѧ}UoD+>m_?VPۅ15&}2|/pIOʵ> GZ9cmíتmnz)yߐbD >e}:) r|@R5qVSA10C%E_'^8cR7O;6[eKePGϦX7jb}OTGO^jn*媓7nGMC t,k31Rb (vyܴʭ!iTh8~ZYZp(qsRL ?b}cŨʊGO^!rPJO15MJ[c&~Z`"ѓޔH1C&^|Ш|rʼ,AwĴ?b5)tLU)F| &g٣O]oqSUjy(x<Ϳ3 .FSkoYg2 \_#wj{u'rQ>o;%n|F*O_L"e9umDds?.fuuQbIWz |4\0 sb;OvxOSs; G%T4gFRurj(֍ڑb uԖKDu1MK{1^ q; C=6\8FR艇!%\YÔU| 88m)֓NcLve C6z;o&X x59:q61Z(T7>C?gcļxѐ Z oo-08jہ x,`' ҔOcRlf~`jj".Nv+sM_]Zk g( UOPyεx%pUh2(@il0ݽQXxppx-NS( WO+轾 nFߢ3M<;z)FBZjciu/QoF 7R¥ ZFLF~#ȣߨ^<쩡ݛкvџ))ME>ώx4m#!-m!L;vv#~Y[đKmx9.[,UFS CVkZ +ߟrY٧IZd/ioi$%͝ب_ֶX3ܫhNU ZZgk=]=bbJS[wjU()*I =ώ:}-蹞lUj:1}MWm=̛ _ ¾,8{__m{_PVK^n3esw5ӫh#$-q=A̟> ,^I}P^J$qY~Q[ Xq9{#&T.^GVj__RKpn,b=`żY@^՝;z{paVKkQXj/)y TIc&F;FBG7wg ZZDG!x r_tƢ!}i/V=M/#nB8 XxЫ ^@CR<{䤭YCN)eKOSƟa $&g[i3.C6xrOc8TI;o hH6P&L{@q6[ Gzp^71j(l`J}]e6X☉#͕ ׈$AB1Vjh㭦IRsqFBjwQ_7Xk>y"N=MB0 ,C #o6MRc0|$)ف"1!ixY<B9mx `,tA>)5ػQ?jQ?cn>YZe Tisvh# GMމȇp:ԴVuږ8ɼH]C.5C!UV;F`mbBk LTMvPʍϤj?ԯ/Qr1NB`9s"s TYsz &9S%U԰> {<ؿSMxB|H\3@!U| k']$U+> |HHMLޢ?V9iD!-@x TIî%6Z*9X@HMW#?nN ,oe6?tQwڱ.]-y':mW0#!J82qFjH -`ѓ&M0u Uγmxϵ^-_\])@0Rt.8/?ٰCY]x}=sD3ojަЫNuS%U}ԤwHH>ڗjܷ_3gN q7[q2la*ArǓԖ+p8/RGM ]jacd(JhWko6ڎbj]i5Bj3+3!\j1UZLsLTv8HHmup<>gKMJj0@H%,W΃7R) ">c, xixј^ aܖ>H[i.UIHc U1=yW\=S*GR~)AF=`&2h`DzT󑓶J+?W+}C%P:|0H܆}-<;OC[~o.$~i}~HQ TvXΈr=b}$vizL4:ȰT|4~*!oXQR6Lk+#t/g lԁߖ[Jڶ_N$k*". xsxX7jRVbAAʯKҎU3)zSNN _'s?f)6X!%ssAkʱ>qƷb hg %n ~p1REGMHH=BJiy[<5 ǁJҖgKR*倳e~HUy)Ag,K)`Vw6bRR:qL#\rclK/$sh*$ 6덤 KԖc 3Z9=Ɣ=o>X Ώ"1 )a`SJJ6k(<c e{%kϊP+SL'TcMJWRm ŏ"w)qc ef꒵i?b7b('"2r%~HUS1\<(`1Wx9=8HY9m:X18bgD1u ~|H;K-Uep,, C1 RV.MR5άh,tWO8WC$ XRVsQS]3GJ|12 [vM :k#~tH30Rf-HYݺ-`I9%lIDTm\ S{]9gOڒMNCV\G*2JRŨ;Rҏ^ڽ̱mq1Eu?To3I)y^#jJw^Ńj^vvlB_⋌P4x>0$c>K†Aļ9s_VjTt0l#m>E-,,x,-W)سo&96RE XR.6bXw+)GAEvL)͞K4$p=Ũi_ѱOjb HY/+@θH9޼]Nԥ%n{ &zjT? Ty) s^ULlb,PiTf^<À] 62R^V7)S!nllS6~͝V}-=%* ʻ>G DnK<y&>LPy7'r=Hj 9V`[c"*^8HpcO8bnU`4JȪAƋ#1_\ XϘHPRgik(~G~0DAA_2p|J묭a2\NCr]M_0 ^T%e#vD^%xy-n}-E\3aS%yN!r_{ )sAw ڼp1pEAk~v<:`'ӭ^5 ArXOI驻T (dk)_\ PuA*BY]yB"l\ey hH*tbK)3 IKZ򹞋XjN n *n>k]X_d!ryBH ]*R 0(#'7 %es9??ښFC,ՁQPjARJ\Ρw K#jahgw;2$l*) %Xq5!U᢯6Re] |0[__64ch&_}iL8KEgҎ7 M/\`|.p,~`a=BR?xܐrQ8K XR2M8f ?`sgWS%" Ԉ 7R%$ N}?QL1|-эټwIZ%pvL3Hk>,ImgW7{E xPHx73RA @RS CC !\ȟ5IXR^ZxHл$Q[ŝ40 (>+ _C >BRt<,TrT {O/H+˟Pl6 I B)/VC<6a2~(XwV4gnXR ϱ5ǀHٻ?tw똤Eyxp{#WK qG%5],(0ӈH HZ])ג=K1j&G(FbM@)%I` XRg ʔ KZG(vP,<`[ Kn^ SJRsAʠ5xՅF`0&RbV tx:EaUE/{fi2;.IAwW8/tTxAGOoN?G}l L(n`Zv?pB8K_gI+ܗ #i?ޙ.) p$utc ~DžfՈEo3l/)I-U?aԅ^jxArA ΧX}DmZ@QLےbTXGd.^|xKHR{|ΕW_h] IJ`[G9{).y) 0X YA1]qp?p_k+J*Y@HI>^?gt.06Rn ,` ?);p pSF9ZXLBJPWjgQ|&)7! HjQt<| ؅W5 x W HIzYoVMGP Hjn`+\(dNW)F+IrS[|/a`K|ͻ0Hj{R,Q=\ (F}\WR)AgSG`IsnAR=|8$}G(vC$)s FBJ?]_u XRvύ6z ŨG[36-T9HzpW̞ú Xg큽=7CufzI$)ki^qk-) 0H*N` QZkk]/tnnsI^Gu't=7$ Z;{8^jB% IItRQS7[ϭ3 $_OQJ`7!]W"W,)Iy W AJA;KWG`IY{8k$I$^%9.^(`N|LJ%@$I}ֽp=FB*xN=gI?Q{٥4B)mw $Igc~dZ@G9K X?7)aK%݅K$IZ-`IpC U6$I\0>!9k} Xa IIS0H$I H ?1R.Чj:4~Rw@p$IrA*u}WjWFPJ$I➓/6#! LӾ+ X36x8J |+L;v$Io4301R20M I$-E}@,pS^ޟR[/s¹'0H$IKyfŸfVOπFT*a$I>He~VY/3R/)>d$I>28`Cjw,n@FU*9ttf$I~<;=/4RD~@ X-ѕzἱI$: ԍR a@b X{+Qxuq$IЛzo /~3\8ڒ4BN7$IҀj V]n18H$IYFBj3̵̚ja pp $Is/3R Ӻ-Yj+L;.0ŔI$Av? #!5"aʄj}UKmɽH$IjCYs?h$IDl843.v}m7UiI=&=0Lg0$I4: embe` eQbm0u? $IT!Sƍ'-sv)s#C0:XB2a w I$zbww{."pPzO =Ɔ\[ o($Iaw]`E).Kvi:L*#gР7[$IyGPI=@R 4yR~̮´cg I$I/<tPͽ hDgo 94Z^k盇΄8I56^W$I^0̜N?4*H`237}g+hxoq)SJ@p|` $I%>-hO0eO>\ԣNߌZD6R=K ~n($I$y3D>o4b#px2$yڪtzW~a $I~?x'BwwpH$IZݑnC㧄Pc_9sO gwJ=l1:mKB>Ab<4Lp$Ib o1ZQ@85b̍ S'F,Fe,^I$IjEdù{l4 8Ys_s Z8.x m"+{~?q,Z D!I$ϻ'|XhB)=…']M>5 rgotԎ 獽PH$IjIPhh)n#cÔqA'ug5qwU&rF|1E%I$%]!'3AFD/;Ck_`9 v!ٴtPV;x`'*bQa w I$Ix5 FC3D_~A_#O݆DvV?<qw+I$I{=Z8".#RIYyjǪ=fDl9%M,a8$I$Ywi[7ݍFe$s1ՋBVA?`]#!oz4zjLJo8$I$%@3jAa4(o ;p,,dya=F9ً[LSPH$IJYЉ+3> 5"39aZ<ñh!{TpBGkj}Sp $IlvF.F$I z< '\K*qq.f<2Y!S"-\I$IYwčjF$ w9 \ߪB.1v!Ʊ?+r:^!I$BϹB H"B;L'G[ 4U#5>੐)|#o0aڱ$I>}k&1`U#V?YsV x>{t1[I~D&(I$I/{H0fw"q"y%4 IXyE~M3 8XψL}qE$I[> nD?~sf ]o΁ cT6"?'_Ἣ $I>~.f|'!N?⟩0G KkXZE]ޡ;/&?k OۘH$IRۀwXӨ<7@PnS04aӶp.:@\IWQJ6sS%I$e5ڑv`3:x';wq_vpgHyXZ 3gЂ7{{EuԹn±}$I$8t;b|591nءQ"P6O5i }iR̈́%Q̄p!I䮢]O{H$IRϻ9s֧ a=`- aB\X0"+5"C1Hb?߮3x3&gşggl_hZ^,`5?ߎvĸ%̀M!OZC2#0x LJ0 Gw$I$I}<{Eb+y;iI,`ܚF:5ܛA8-O-|8K7s|#Z8a&><a&/VtbtLʌI$I$I$I$I$I$IRjDD%tEXtdate:create2022-05-31T04:40:26+00:00!Î%tEXtdate:modify2022-05-31T04:40:26+00:00|{2IENDB`Mini Shell

HOME


Mini Shell 1.0
DIR:/home/dna1981/mail/.spam/new/
Upload File :
Current File : /home/dna1981/mail/.spam/new/1611086747.M429393P17432.dna.dna-1981.com,S=11295,W=11501
Return-Path: <12037-14500-10614-1939-c.wilson=smithfamilycarpets.com@mail.obarivat.life>
Delivered-To: dna1981+spam@dna.dna-1981.com
Received: from dna.dna-1981.com
	by dna.dna-1981.com with LMTP
	id 6N5+GZs7B2AYRAAAff7CYA
	(envelope-from <12037-14500-10614-1939-c.wilson=smithfamilycarpets.com@mail.obarivat.life>)
	for <dna1981+spam@dna.dna-1981.com>; Tue, 19 Jan 2021 14:05:47 -0600
Return-path: <12037-14500-10614-1939-c.wilson=smithfamilycarpets.com@mail.obarivat.life>
Envelope-to: c.wilson@smithfamilycarpets.com
Delivery-date: Tue, 19 Jan 2021 14:05:47 -0600
Received: from [23.247.22.44] (port=45008 helo=maria.obarivat.life)
	by dna.dna-1981.com with esmtp (Exim 4.93)
	(envelope-from <12037-14500-10614-1939-c.wilson=smithfamilycarpets.com@mail.obarivat.life>)
	id 1l1xFq-0004We-1L
	for c.wilson@smithfamilycarpets.com; Tue, 19 Jan 2021 14:05:47 -0600
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=obarivat.life;
 h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=edsolution@obarivat.life;
 bh=oEz6tX9JK+QukScalL8jKl51JFQ=;
 b=dQj6emha1fQjY27X8IHgyqZJN24BJ2XTTmBQXWF3Cdj2dUb+gU51STquxYPRJsU6ArPP62tJ/RSZ
   orCPBHsHY8AoMK9fA0DDGEPQHyzSf2ysaoJz4gl3PfJtstpxp8RmSVw2UqYyFw1GZuv4VCoxK/h7
   pF+rhxVMXDgPl0pdZrU=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=obarivat.life;
 b=gOsNrrqXFOdCoMqMVh4Q/iknMpzmQKjiLkCyGVfmRhiadESShMdWk3lzsvpRAXQIpjCc1S20J/cl
   9BtvMo5eQ1Su1MbmGnqsV8h1GL1WnqtsCBjyATtzVm0FNdi0mdu8SJ2MmKzm2DUrok/yxGXzsy1L
   ZX70Jh1ORdywL3CxXjI=;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="be0c39dce6e640d86e35d8143ce0112b"
Date: Tue, 19 Jan 2021 14:04:19 -0600
From: "Stop Erectile Dysfunction" <edsolution@obarivat.life>
Reply-To: "Prevent ED" <edsolution@obarivat.life>
To: <c.wilson@smithfamilycarpets.com>
Message-ID: <8fx2jc49wn364tro-634z4wz9wuokndhf-2976@obarivat.life>
X-Spam-Status: Yes, score=18.9
X-Spam-Score: 189
X-Spam-Bar: ++++++++++++++++++
X-Spam-Report: Spam detection software, running on the system "dna.dna-1981.com",
 has identified this incoming email as possible spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  This email must be viewed in HTML mode. I’ve got something
    really exciting to share with you today... It's a brand new method for helping
    men get and stay rock-hard in bed and overcome E.D. 
 Content analysis details:   (18.9 points, 4.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  5.0 BAYES_99               BODY: Bayes spam probability is 99 to 100%
                             [score: 1.0000]
  1.0 BAYES_999              BODY: Bayes spam probability is 99.9 to 100%
                             [score: 1.0000]
  2.0 PDS_OTHER_BAD_TLD      Untrustworthy TLDs
                             [URI: obarivat.life (life)]
  0.0 T_SPF_HELO_TEMPERROR   SPF: test of HELO record failed (temperror)
  0.0 T_SPF_TEMPERROR        SPF: test of record failed (temperror)
  0.1 MIME_HTML_MOSTLY       BODY: Multipart message mostly text/html MIME
  0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or
                             identical to background
  0.8 MPART_ALT_DIFF         BODY: HTML and text parts are different
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
  0.9 RAZOR2_CHECK           Listed in Razor2 (http://razor.sf.net/)
  1.9 RAZOR2_CF_RANGE_51_100 Razor2 gives confidence level above 50%
                             [cf: 100]
  0.5 FROM_SUSPICIOUS_NTLD   From abused NTLD
  1.8 FROM_SUSPICIOUS_NTLD_FP From abused NTLD
  2.0 RDNS_NONE              Delivered to internal network by a host with no rDNS
  0.8 KAM_INFOUSMEBIZ        Prevalent use of
                             .info|.us|.me|.me.uk|.biz|xyz|id|rocks|life
                              domains in spam/malware
  0.0 FSL_BULK_SIG           Bulk signature with no Unsubscribe
  2.1 NORDNS_LOW_CONTRAST    No rDNS + hidden text
X-Spam-Flag: YES
Subject:    New Breakthrough Method For Curing E.D. And Getting Hard In Bed

--be0c39dce6e640d86e35d8143ce0112b
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit

This email must be viewed in HTML mode.

--be0c39dce6e640d86e35d8143ce0112b
Content-Type: text/html;
Content-Transfer-Encoding: 8bit

<html>
<head>
	<title></title>
	<style type="text/css">
	</style>
</head>
<body style="background-color:#ffffff;"><a href="http://obarivat.life/JsMgBPiNyNNdRVStIYl-Mdm_SPypxsRxm1xzmCLXvNrjPtQ1"><img border="0" src="http://obarivat.life/Kl5HES65VA2xGMOgEtMRuZpElnE_4l9ctA2yGn8RtHuupzW-" /> </a>
<table align="center" border="0" cellpadding="35" cellspacing="0" style="color: rgb(34, 34, 34); font-size: 16px; font-family: Arial, sans-serif; text-align: justify; border: 5px solid #000000; background-color: rgb(255, 255, 255);" width="650">
	<tbody>
		<tr>
			<td style="font-family: arial, sans-serif; margin: 0px; height: 125px;">
			<div align="left">
			<div>
			<div style="color: rgb(51, 51, 51); font-family: Arial, Verdana, sans-serif; font-size: 13.3333px;">
			<div><span style="font-size: 20px;">I&rsquo;ve got something really exciting to share with you today... </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">It&#39;s a brand new method for helping men get and stay rock-hard in bed and overcome E.D. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">The man behind this method is Jack Grave.</span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">In case you haven&#39;t heard of Jack, he&#39;s an author and an Expert Men&#39;s Sexual Health Advisor, which is why I&#39;m particularly passionate about this new method.</span></div>

			<div>&nbsp;</div>

			<p><a href="http://obarivat.life/SsmlQ9zx2fCmhboXAjV16q7Ps1wt9D2CQiy2IH0S26w_Wqf_"><img src="http://obarivat.life/742f54e1b1d3f6f0ed.jpg" /></a></p>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">Jack has created a video walking through exactly how this new method works and as a subscriber of mine you can currently <strong><a href="http://obarivat.life/SsmlQ9zx2fCmhboXAjV16q7Ps1wt9D2CQiy2IH0S26w_Wqf_">check out the video for free here... </a></strong> </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">By the way, the new method you&#39;ll discover in this video is like NOTHING else out there for helping with E.D., getting hard and satisfying women in bed. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">No meds, no weird pumps, it doesn&#39;t matter how old you are, what your genetics are like or how big you are &quot;down there&quot;. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">This is a revolutionary new approach. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">And no matter whether you have a small occasional problem with getting hard or it&#39;s a severe issue for you, this will help you to solve it and therefore give your lover a lot more pleasure in bed. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;"><strong><a href="http://obarivat.life/SsmlQ9zx2fCmhboXAjV16q7Ps1wt9D2CQiy2IH0S26w_Wqf_">Go check out Jack&#39;s video for the limited time it&#39;s up here...</a></strong> </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">Edwin </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">PS - As you&#39;ll discover in this video there&#39;s ONE MAJOR REASON why many men struggle with E.D. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;">If you can fix this one problem, as you&#39;ll discover how to do in this video, you&#39;ll be amazed at how much more control you have over your ability to get hard, and therefore to satisfy your lover. </span></div>

			<div>&nbsp;</div>

			<div><span style="font-size: 16px;"><strong><a href="http://obarivat.life/SsmlQ9zx2fCmhboXAjV16q7Ps1wt9D2CQiy2IH0S26w_Wqf_">Watch this video now...</a></strong> </span></div>
			</div>
			</div>
			</div>
			</td>
		</tr>
	</tbody>
</table>
<br />
<br />
<br />
<br />
<br />
&nbsp;
<p align="center"><a href="http://obarivat.life/d1VsEm-MftwAvOFMOvrf1x9Hh7hmZ12keznM82nMVQut7uvg" style="color:#ffffff;"><img alt="Unsu_bscribe From Here" src="http://obarivat.life/f6311b491cdf9d64f0.jpg" /></a></p>
<br />
<br />
<br />
<br />
<br />
<br />
&nbsp; <span style="color:#ffffff;"> Further ination: Management of Tourette syndrome &sect; Medication Little white pills on a counter, next to a pill bottle and labels Clonidine is one of the medications typiy tried first when medication is needed for Tourette&#39;s. It is available as a pill or a transdermal (skin) patch. Children with tics typiy present when their tics are most severe, but because the condition waxes and wanes, medication is not started immediately or changed often. Tics may subside with education, reassurance and a supportive environment. When medication is used, the goal is not to eliminate symptoms. Inste, the lowest dose that manages symptoms without verse effects is used, because verse effects may be more disturbing than the symptoms being treated with medication. The classes of medication with proven efficacy in treating tics&mdash;typical and atypical neuroleptics&mdash;can have long-term and short-term verse effects. Some antihypertensive agents are also used to treat tics; studies show variable efficacy but a lower side effect profile than the neuroleptics. The antihypertensives clonidine and guanfacine are typiy tried first in children; they can also help with HD symptoms, but t is less evidence that they are effective for ults. The neuroleptics risperidone and aripiprazole are tried when antihypertensives are not effective, and are generally tried first for ults. The most effective medication for tics is haloperidol, but it has a higher risk of side effects. Methylphenidate can be used to treat HD that co-occurs with tics, and can be used in combination with clonidine. Selective serotonin reuptake inhibitors are used to manage anxiety and OCD. Other Further ination: Management of Tourette syndrome &sect; Other Complementary and alternative approaches, such as dietary modification, neurofeedback and allergy testing and control have popular appeal, but they have no proven benefit in the management of Tourette syndrome. Despite this lack of evidence, up to two-thirds of parents, caregivers and individuals with TS use dietary approaches and alternative treatments and do not always in their physicians. </span>

<table align="center" bgcolor="#ffffff" width="100%">
	<tbody>
		<tr>
			<td align="center">
			<p><br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<br />
			<a href="http://obarivat.life/5bHJllziFWAA8mG2zN21Nxv6A--3Irb7eFob1oBV9klKkvdX"><img src="http://obarivat.life/ae2de2f109bbb2d5dc.jpg" /></a></p>
			</td>
		</tr>
	</tbody>
</table>
</body>
</html>

--be0c39dce6e640d86e35d8143ce0112b--